Study aims to help stratify risks associated with new devices for treating pulmonary embolism

Pulmonary embolism (PE), a blood clot lodged in one of the pulmonary arteries in the lungs, is the third leading cause of cardiovascular-related death in the United States. While most patients are treated with anticoagulants (commonly known as blood thinners), the use of novel interventional devices that remove or dissolve clots in the lungs has significantly increased in recent years.

from http://besthealthnews.com/2019/10/study-aims-to-help-stratify-risks-associated-with-new-devices-for-treating-pulmonary-embolism/?utm_source=rss&utm_medium=rss&utm_campaign=study-aims-to-help-stratify-risks-associated-with-new-devices-for-treating-pulmonary-embolism

from
https://healthnews010.tumblr.com/post/188162738688

from https://johnher1.blogspot.com/2019/10/study-aims-to-help-stratify-risks.html

from
https://johnher10.tumblr.com/post/188162968532

From https://stevenbrown1.blogspot.com/2019/10/study-aims-to-help-stratify-risks.html

from
https://stevenbrown11.wordpress.com/2019/10/06/study-aims-to-help-stratify-risks-associated-with-new-devices-for-treating-pulmonary-embolism/